• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Femasys Inc. - Common Stock (NQ:FEMY)

    0.3545 +0.0095 (+2.75%)
    Streaming Delayed Price Updated: 3:44 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 781,545
    Open 0.3582
    Bid (Size) 0.3540 (11)
    Ask (Size) 0.3559 (2)
    Prev. Close 0.3450
    Today's Range 0.3336 - 0.3582
    52wk Range 0.3067 - 1.800
    Shares Outstanding 11,813,610
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
    -- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access -- 
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
    Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination 
    From Femasys Inc.
    Via GlobeNewswire

    Performance

    YTD
    -67.8%
    -67.8%
    1 Month
    -5.7%
    -5.7%
    3 Month
    -63.9%
    -63.9%
    6 Month
    -73.4%
    -73.4%
    1 Year
    -68.6%
    -68.6%

    More News

    Read More
    Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
    From Femasys Inc.
    Via GlobeNewswire
    Top stock movements in today's session.
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Tuesday's session: top gainers and losers
    Via Chartmill
    Crude Oil Down 2%; US Durable Goods Orders Decline In July
    Via Benzinga
    Traders are paying attention to the gapping stocks in Tuesday's session.
    Via Chartmill
    US Stocks Mixed; American Woodmark Posts Downbeat Sales
    Via Benzinga
    Tuesday's pre-market session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Revenue Jumps 85 Percent in Q2
    Via The Motley Fool
    Topics Intellectual Property
    Femasys Announces Second Quarter Financial Results for 2025
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
    From Femasys Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
    From Femasys Inc.
    Via GlobeNewswire
    The Analyst Verdict: Femasys In The Eyes Of 6 Experts
    Via Benzinga

    Frequently Asked Questions

    Is Femasys Inc. - Common Stock publicly traded?
    Yes, Femasys Inc. - Common Stock is publicly traded.
    What exchange does Femasys Inc. - Common Stock trade on?
    Femasys Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Femasys Inc. - Common Stock?
    The ticker symbol for Femasys Inc. - Common Stock is FEMY on the Nasdaq Stock Market
    What is the current price of Femasys Inc. - Common Stock?
    The current price of Femasys Inc. - Common Stock is 0.3545
    When was Femasys Inc. - Common Stock last traded?
    The last trade of Femasys Inc. - Common Stock was at 09/26/25 03:44 PM ET
    What is the market capitalization of Femasys Inc. - Common Stock?
    The market capitalization of Femasys Inc. - Common Stock is 4.19M
    How many shares of Femasys Inc. - Common Stock are outstanding?
    Femasys Inc. - Common Stock has 4M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.